S&P 500   5,089.24 (+0.04%)
DOW   39,100.32 (+0.08%)
QQQ   437.29 (-0.18%)
AAPL   182.57 (-0.98%)
MSFT   409.97 (-0.41%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.22 (-0.21%)
TSLA   192.53 (-2.47%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.94 (-0.24%)
T   16.80 (+1.27%)
F   12.16 (+0.33%)
MU   85.91 (+0.00%)
CGC   3.40 (+0.89%)
GE   153.30 (+1.07%)
DIS   107.65 (+0.01%)
AMC   4.47 (+1.13%)
PFE   27.82 (+0.98%)
PYPL   59.20 (+1.46%)
XOM   103.88 (-0.84%)
S&P 500   5,089.24 (+0.04%)
DOW   39,100.32 (+0.08%)
QQQ   437.29 (-0.18%)
AAPL   182.57 (-0.98%)
MSFT   409.97 (-0.41%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.22 (-0.21%)
TSLA   192.53 (-2.47%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.94 (-0.24%)
T   16.80 (+1.27%)
F   12.16 (+0.33%)
MU   85.91 (+0.00%)
CGC   3.40 (+0.89%)
GE   153.30 (+1.07%)
DIS   107.65 (+0.01%)
AMC   4.47 (+1.13%)
PFE   27.82 (+0.98%)
PYPL   59.20 (+1.46%)
XOM   103.88 (-0.84%)
S&P 500   5,089.24 (+0.04%)
DOW   39,100.32 (+0.08%)
QQQ   437.29 (-0.18%)
AAPL   182.57 (-0.98%)
MSFT   409.97 (-0.41%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.22 (-0.21%)
TSLA   192.53 (-2.47%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.94 (-0.24%)
T   16.80 (+1.27%)
F   12.16 (+0.33%)
MU   85.91 (+0.00%)
CGC   3.40 (+0.89%)
GE   153.30 (+1.07%)
DIS   107.65 (+0.01%)
AMC   4.47 (+1.13%)
PFE   27.82 (+0.98%)
PYPL   59.20 (+1.46%)
XOM   103.88 (-0.84%)
S&P 500   5,089.24 (+0.04%)
DOW   39,100.32 (+0.08%)
QQQ   437.29 (-0.18%)
AAPL   182.57 (-0.98%)
MSFT   409.97 (-0.41%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.22 (-0.21%)
TSLA   192.53 (-2.47%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.94 (-0.24%)
T   16.80 (+1.27%)
F   12.16 (+0.33%)
MU   85.91 (+0.00%)
CGC   3.40 (+0.89%)
GE   153.30 (+1.07%)
DIS   107.65 (+0.01%)
AMC   4.47 (+1.13%)
PFE   27.82 (+0.98%)
PYPL   59.20 (+1.46%)
XOM   103.88 (-0.84%)
LON:IQAI

IQ-AI (IQAI) Share Price, News & Analysis

GBX 1.63
+0.08 (+5.16%)
(As of 04:35 PM ET)
Today's Range
1.50
1.63
50-Day Range
1.52
5.05
52-Week Range
1.40
5.80
Volume
1.52 million shs
Average Volume
1.13 million shs
Market Capitalization
£3.21 million
P/E Ratio
N/A
Dividend Yield
17.30%
Price Target
N/A

IQAI stock logo

About IQ-AI Stock (LON:IQAI)

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey, the United Kingdom, and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company is based in Saint Helier, Jersey.

IQAI Stock Price History

IQAI Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Iq-ai Ltd Share Chat
IQ-AI subsidiary secures second orphan drug designation
IQ-AI subsidairy secures second orphan drug designation
Iq-ai Ltd Share Price (IQAI)
IQ-AI shares stop trading on US OTCQB Venture Market
IQ-AI hails latest data on IB Neuro technology
See More Headlines
Receive IQAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IQ-AI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£538,190.00
Cash Flow
GBX 0.15 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.95 million
Optionable
Not Optionable
Beta
2.96
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Trevor Edward Brown M.B.A. (Age 78)
    CEO & Director
    Comp: $100k
  • Mr. David W. J. Smith
    Chief Operating Officer














IQAI Stock Analysis - Frequently Asked Questions

How have IQAI shares performed in 2024?

IQ-AI's stock was trading at GBX 4.70 at the start of the year. Since then, IQAI shares have decreased by 65.3% and is now trading at GBX 1.63.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of IQ-AI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IQ-AI investors own include Macerich (MAC), Merck & Co., Inc. (MRK), Pfizer (PFE), Scotts Miracle-Gro (SMG), Xilinx (XLNX), Arista Networks (ANET), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER) and Aimmune Therapeutics (AIMT).

How do I buy shares of IQ-AI?

Shares of IQAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:IQAI) was last updated on 2/23/2024 by MarketBeat.com Staff